Search

Quanterix Corp

Chiusa

SettoreSettore sanitario

2.91 13.23

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

2.57

Massimo

2.94

Metriche Chiave

By Trading Economics

Entrata

-31M

-49M

Vendite

-3.5M

33M

EPS

-0.45

Margine di Profitto

-148.708

Dipendenti

450

EBITDA

-38M

-49M

Raccomandazioni

By TipRanks

Raccomandazioni

Neutrale

Previsioni per 12 mesi

+15.83% upside

Dividendi

By Acuity

Utili prossimi

9 nov 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-45M

114M

Apertura precedente

-10.32

Chiusura precedente

2.91

Notizie sul Sentiment di mercato

By Acuity

38%

62%

121 / 340 Classifica in Healthcare

Quanterix Corp Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

17 ago 2026, 20:01 UTC

News

Quanterix Corp shares are higher after Director William P. Donnelly's insider purchase of 72,245 shares at $2.93, despite a price target cut by Canaccord Genuity.

14 ago 2026, 23:01 UTC

Quanterix Corp shares are higher in after-market trading, despite no specific news. This follows mixed market sentiment after a decline in U.S. retail sales.

13 ago 2026, 20:02 UTC

Quanterix Corp shares are lower today amid a broader decline in the Life Sciences Tools & Services sub-sector, continuing a downward trend since Wednesday.

12 ago 2026, 23:01 UTC

Quanterix Corp. shares are trading roughly flat in after-market hours. The stock has seen a significant decline over the past month, remaining below its 20-day moving average.

11 ago 2026, 22:51 UTC

Quanterix Corp shares are lower in after-market hours, continuing a decline from Tuesday's close amid broader market pressure and rising crude oil prices.

10 ago 2026, 19:51 UTC

Event
Social Media
News

Quanterix Corp reported a wider second-quarter loss and lowered full-year revenue guidance, leading to a significant decline in shares amid investor concerns.

7 ago 2026, 19:16 UTC

Quanterix Corp shares are higher today, continuing a trend with three consecutive sessions of gains since Thursday. The stock is trading above its 20-day moving average.

5 ago 2026, 19:23 UTC

Quanterix Corp shares are higher, supported by a broader rise in the Life Sciences Tools & Services sector. The stock remains below its 20-day moving average.

3 ago 2026, 19:26 UTC

Quanterix Corp shares are higher today, tracking broader market gains amid rising confidence in tech stocks and falling energy prices.

31 lug 2026, 19:46 UTC

Quanterix Corp shares are higher today, reflecting a modest gain since Thursday's close. The stock is near the lower end of its one-month range.

30 lug 2026, 19:59 UTC

Quanterix Corp is trading higher amid a broader recovery in tech shares. The asset has shown notable volatility, pulling back from earlier session highs.

29 lug 2026, 19:43 UTC

Macro Event

Quanterix Corp's shares are lower today amid broader market declines, reflecting heightened volatility following the Federal Reserve's decision to maintain interest rates.

28 lug 2026, 20:06 UTC

Quanterix Corp shares are declining amid broader market weakness, with the Nikkei 225 dropping significantly due to concerns over AI spending and semiconductor competition.

27 lug 2026, 16:06 UTC

Quanterix Corp shares are higher today, following a strong opening. No specific news was identified to explain the price movement.

24 lug 2026, 19:53 UTC

Quanterix Corp shares are lower today, continuing a decline since Thursday amid broader market uncertainty from oil volatility and new U.S. tariffs.

22 lug 2026, 19:36 UTC

Quanterix Corp shares are lower in Wednesday's session, continuing a decline since Tuesday's close amid rising crude oil prices and market concerns.

21 lug 2026, 21:26 UTC

Quanterix Corp shares are higher in after-market hours, reflecting positive trading momentum. Broader market strength may be influencing sentiment following the close.

20 lug 2026, 19:46 UTC

Quanterix Corp shares are higher today amid positive market sentiment and a notable rise in the Hang Seng 50 Index, despite no specific company news.

Confronto tra pari

Modifica del prezzo

Quanterix Corp Previsione

Obiettivo di Prezzo

By TipRanks

15.83% in crescita

Previsioni per 12 mesi

Media 3 USD  15.83%

Alto 3 USD

Basso 3 USD

Basato su 2 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Quanterix Corp - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Neutrale

2 ratings

0

Acquista

2

Mantieni

0

Vendi

Sentiment

By Acuity

121 / 340 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sopra la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
help-icon Live chat